serine has been researched along with Dyskinesia, Drug-Induced in 7 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "While Parkinson's disease (PD) phenotype in leucine-rich repeat kinase 2 gene (LRRK2)-associated and sporadic PD seems similar, there is paucity of data on the possible effect of mutations in LRRK2 on response to and complications of dopaminergic therapy." | 1.38 | Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. ( Cohen, OS; Friedman, E; Hassin-Baer, S; Inzelberg, R; Kaplan, N; Korczyn, AD; Kozlova, E; Rosset, S; Vituri, A; Yahalom, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paus, S | 1 |
| Gadow, F | 1 |
| Knapp, M | 1 |
| Klein, C | 1 |
| Klockgether, T | 1 |
| Wüllner, U | 1 |
| Morissette, M | 1 |
| Samadi, P | 1 |
| Hadj Tahar, A | 1 |
| Bélanger, N | 1 |
| Di Paolo, T | 1 |
| Yahalom, G | 1 |
| Kaplan, N | 1 |
| Vituri, A | 1 |
| Cohen, OS | 1 |
| Inzelberg, R | 1 |
| Kozlova, E | 1 |
| Korczyn, AD | 1 |
| Rosset, S | 1 |
| Friedman, E | 1 |
| Hassin-Baer, S | 1 |
| Bakker, PR | 1 |
| van Harten, PN | 1 |
| van Os, J | 1 |
| Liou, YJ | 1 |
| Lai, IC | 1 |
| Liao, DL | 1 |
| Chen, JY | 1 |
| Lin, CC | 1 |
| Lin, CY | 1 |
| Chen, CM | 1 |
| Bai, YM | 1 |
| Chen, TT | 1 |
| Wang, YC | 1 |
| Segman, R | 1 |
| Neeman, T | 1 |
| Heresco-Levy, U | 1 |
| Finkel, B | 1 |
| Karagichev, L | 1 |
| Schlafman, M | 1 |
| Dorevitch, A | 1 |
| Yakir, A | 1 |
| Lerner, A | 1 |
| Shelevoy, A | 1 |
| Lerer, B | 2 |
| Segman, RH | 1 |
| Fangerau, H | 1 |
| Daly, AK | 1 |
| Basile, VS | 1 |
| Cavallaro, R | 1 |
| Aschauer, HN | 1 |
| McCreadie, RG | 1 |
| Ohlraun, S | 1 |
| Ferrier, N | 1 |
| Masellis, M | 1 |
| Verga, M | 1 |
| Scharfetter, J | 1 |
| Rietschel, M | 1 |
| Lovlie, R | 1 |
| Levy, UH | 1 |
| Meltzer, HY | 1 |
| Kennedy, JL | 1 |
| Steen, VM | 1 |
| Macciardi, F | 1 |
1 review available for serine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
Topics: Adult; Aged; Analysis of Variance; Chi-Square Distribution; Confidence Intervals; Dyskinesia, Drug-I | 2002 |
6 other studies available for serine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Community Networks; Dyskinesia, Drug-Induced; Female; | 2009 |
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.
Topics: Animals; Antiparkinson Agents; Benzoxazoles; Cabergoline; Corpus Striatum; Disease Models, Animal; D | 2010 |
Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.
Topics: Adult; Aged; Aged, 80 and over; DNA Mutational Analysis; Dyskinesia, Drug-Induced; Female; Gene Freq | 2012 |
Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis.
Topics: Alleles; Antipsychotic Agents; Chi-Square Distribution; Dyskinesia, Drug-Induced; Female; Glycine; H | 2006 |
The human dopamine receptor D2 (DRD2) gene is associated with tardive dyskinesia in patients with schizophrenia.
Topics: Antipsychotic Agents; Case-Control Studies; Dyskinesia, Drug-Induced; Female; Genetic Predisposition | 2006 |
Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Genotype; Glycine; Humans; Israel; Je | 1999 |